Sino Biopharmaceutical surges 3% in Hong Kong trading
HK Stock Market Update·Top 10 HK Stock Gainers (8.20)
Top Gainers&Losers·Top 5 HK Stock Gainers/Losers (>100B) (8.20)
Top Gainers&Losers·- On August 20, the Hang Seng Index rose 0.8% and the Hang Seng Tech Index increased by 0.39%. - Among Hong Kong stocks with a market value exceeding 100 billion, Sino Biopharmaceutical surged 12.53% and Zijin Gold International gained 11.25%. - Conversely, Kuaishou-W dropped 11.01% and Hengrui Pharma declined 9.63%.HK Midday: HSI up 1.22%; Innovator Drug Stocks Surge, Everest Medicines Soars Nearly 60%
Market Pulse·- Hong Kong stocks maintained an upward trend on August 20, with the Hang Seng Index rising 1.22% to 25807.29 points. - The innovative drug sector surged significantly driven by Moderna mRNA vaccine developments and strong interim results, while gold stocks strengthened as spot gold broke 4500 USD. - Meanwhile, internet technology stocks showed divergence, highlighted by Kuaishou dropping over 10% following weaker-than-expected financial results.HSI Gains 291 pts at Half-day; KUAISHOU-W Slumps Nearly 10% After Results; SBP GROUP Surges 16% After Results; Innovative Drug, Gold Mining Stocks Rally
AASTOCKS News·- Hong Kong stocks closed higher at midday on August 20, 2026, with the Hang Seng Index up 291 points or 1.14% at 25,786. - The morning session featured significant market movements, including a 9.74% slump in Kuaishou-W following weak results and a 16.18% surge in Sbp Group driven by strong interim profit. - Innovative drug and gold mining stocks rallied broadly, supported by external pharmaceutical clinical trial breakthroughs and spot gold prices breaking above USD4,500 per ounce.